Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Testofen is a proprietary, standardized extract of fenugreek (*Trigonella foenum-graecum*) seeds, developed and manufactured by Gencor. It is standardized to a specific group of saponin glycosides known as Fenuside. Testofen is primarily utilized as a dietary supplement and nutraceutical ingredient aimed at supporting male reproductive health, specifically by increasing free testosterone levels, enhancing libido, and improving erectile function. Clinical research, including randomized controlled trials, has demonstrated its efficacy in reducing symptoms of androgen deficiency and improving sexual performance in aging men. Additionally, it is used in sports nutrition contexts to support muscle mass and physical strength.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on testofen.